The levels of serum Linc00152 and UCA1 were significantly increased in HCC patients, and the panel of serum linc00152, UCA1, and AFP showed significant predictive ability, with an AUC of 0.912 and sensitivity and specificity of 82.9% and 88.2%, respectively [72]. The gene discussed is UCA1; the disease is hepatocellular carcinoma.